| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
IQVIA Holdings Inc (NYSE: IQV)
IQV Technical Analysis
4
| As on 9th Jun 2023 IQV STOCK Price closed @ 206.59 and we RECOMMEND Sell for LONG-TERM with Stoploss of 222.34 & Strong Sell for SHORT-TERM with Stoploss of 247.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IQVSTOCK Price
| Open | 207.25 | Change | Price | % |
| High | 207.57 | 1 Day | 0.40 | 0.19 |
| Low | 203.79 | 1 Week | 9.68 | 4.92 |
| Close | 206.59 | 1 Month | 22.93 | 12.49 |
| Volume | 973479 | 1 Year | -62.04 | -23.09 |
| 52 Week High 282.61 | 52 Week Low 171.86 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| IQV Daily Charts |
IQV Intraday Charts |
Whats New @ Bazaartrend |
IQV Free Analysis |
|
|
IQV Important Levels Intraday
| RESISTANCE | 213.87 |
| RESISTANCE | 211.54 |
| RESISTANCE | 210.09 |
| RESISTANCE | 208.65 |
| SUPPORT | 204.53 |
| SUPPORT | 203.09 |
| SUPPORT | 201.64 |
| SUPPORT | 199.31 |
IQV Forecast April 2024
| 4th UP Forecast | 283.96 |
| 3rd UP Forecast | 259.15 |
| 2nd UP Forecast | 243.81 |
| 1st UP Forecast | 228.47 |
| 1st DOWN Forecast | 184.71 |
| 2nd DOWN Forecast | 169.37 |
| 3rd DOWN Forecast | 154.03 |
| 4th DOWN Forecast | 129.22 |
IQV Weekly Forecast
| 4th UP Forecast | 248.17 |
| 3rd UP Forecast | 234.84 |
| 2nd UP Forecast | 226.59 |
| 1st UP Forecast | 218.35 |
| 1st DOWN Forecast | 194.83 |
| 2nd DOWN Forecast | 186.59 |
| 3rd DOWN Forecast | 178.34 |
| 4th DOWN Forecast | 165.01 |
IQV Forecast2024
| 4th UP Forecast | 437.56 |
| 3rd UP Forecast | 363.49 |
| 2nd UP Forecast | 317.7 |
| 1st UP Forecast | 271.91 |
| 1st DOWN Forecast | 141.27 |
| 2nd DOWN Forecast | 95.48 |
| 3rd DOWN Forecast | 49.69 |
| 4th DOWN Forecast | -24.38 |
IQVIA Holdings Inc ( NYSE USA Symbol : IQV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IQV Business Profile
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. IQVIA has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina. Address: 4820 Emperor Blvd., Durham, NC, United States, 27703
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service